Skip to main content

Clover Health Investments, Corp.

CLOV
Exchange
Nasdaq
Industry
Hospital & Medical Service Plans
SEC CIK
0001801170

In the last 90 days, Clover Health Investments, Corp. insiders filed 0 open-market purchases and 17 sales; 228 institutions reported holding it in 13F filings for Q3 2026, worth $676.4M in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $3.80M in total
17
13F holdersQ3 2026, +8 vs. previous quarter
228
13F valueReported value at the end of Q3 2026
$676.4M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$1.92B
+40.3% year over year
Net income, FY2025
-$85.5M
No comparable prior period
Free cash flow, FY2025
-$69.0M
−307.2% year over year
Revenue, Q3 FY2026
$759.3M
+52.9% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $85.5M (4.4% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
23.0M
Shares sold short
Change
−2.92M
−11.3% vs. previous
Days to cover
6.73
At average daily volume

Superinvestors holding CLOV, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding CLOV at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Clover Health Investments, Corp. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)5:03 PM ETNov 161 dayThornton Joseph ClayChief Financial OfficerSSaleClass A Common Stock−22.1K$4.97−$109.8K−1.4%1.55M after
Oct 20, 2026 (view filing)5:56 PM ETOct 20Same daySoares KarenChief Legal OfficerSSaleClass A Common Stock−19.3K$4.66−$89.8K−1.2%1.57M after10b5-1
Oct 20, 2026 (view filing)4:43 PM ETOct 191 dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−4.07K$4.41−$17.9K−0.1%2.77M after10b5-1
Oct 19, 2026 (view filing)4:31 PM ETOct 154 daysToy AndrewChief Executive OfficerSSaleClass A Common Stock−62.2K$4.68−$291.0K−0.7%9.08M after10b5-1
Oct 19, 2026 (view filing)4:26 PM ETOct 154 daysSoares KarenChief Legal OfficerSSaleClass A Common Stock−14.7K$4.68−$68.7K−0.9%1.59M after10b5-1
Oct 19, 2026 (view filing)4:23 PM ETOct 154 daysThornton Joseph ClayInterim CFOSSaleClass A Common Stock−4.59K$4.68−$21.5K−0.4%1.24M after10b5-1
Oct 19, 2026 (view filing)4:22 PM ETOct 154 daysWai ConradCEO, Counterpart HealthSSaleClass A Common Stock−23.6K$4.68−$110.6K−2.2%1.04M after10b5-1
Oct 19, 2026 (view filing)4:19 PM ETOct 154 daysReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−18.3K$4.68−$85.5K−0.7%2.77M after10b5-1
Oct 7, 2026 (view filing)6:20 PM ETOct 7Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−2.01K$4.63−$9.29K−0.1%2.79M after10b5-1
Oct 5, 2026 (view filing)7:00 PM ETOct 5Same dayReynoso Jamie L.CEO, Medicare AdvantageSSaleClass A Common Stock−8.75K$4.42−$38.7K−0.3%2.79M after10b5-1

Top 10 13F holders, Q3 2026

See all 228 holders

The largest institutional positions in Clover Health Investments, Corp. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding CLOV in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.36,508,668$157.4M0.00%+1,401,703+4.0%Added
Vanguard Capital Management LLC18,381,770$79.2M0.00%+344,109+1.9%Added
Geode Capital Management, LLC11,115,990$47.9M0.00%+269,924+2.5%Added
State Street Corp10,693,705$46.1M0.00%+513,368+5.0%Added
Nuveen, LLC7,818,023$33.7M0.01%+1,526,324+24.3%Added
Vanguard Portfolio Management LLC7,590,927$32.7M0.00%+3,120,475+69.8%Added
Charles Schwab Investment Management Inc5,859,804$25.3M0.00%+338,616+6.1%Added
Renaissance Technologies LLC4,554,241$19.6M0.03%+1,746,800+62.2%Added
D. E. Shaw & Co., Inc.4,382,346$18.9M0.01%+2,416,853+123.0%Added
Northern Trust Corp3,779,279$16.3M0.00%+6,679+0.2%Added

Holders of 5% or more of CLOV

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Clover Health Investments, Corp..

Largest holders of CLOV from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G7.20%29.8M sharesNewJul 17, 20251 filingJul 17, 2025SEC